Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Lumbosacral Radiculopathy
Interventions
DRUG

z160

DRUG

Placebo

Trial Locations (23)

16635

Investigative Site, Duncansville

30342

Investigative Site, Atlanta

32806

Investigative Site, Orlando

33317

Investigative Site, Plantation

33411

Investigative Site, Royal Palm Beach

33756

Investigative Site, Clearwater

33765

Investigative Site, Clearwater

33781

Investigative Site, Pinellas Park

35801

Investigative Site, Huntsville

63042

Investigative Site, Hazelwood

66210

Investigative Site, Overland Park

71105

Investigative Site, Shreveport

75230

Investigative Site, Dallas

84070

Investigative Site, Sandy City

85381

Investigative Site, Peoria

89144

Investigative Site, Las Vegas

92804

Investigative Site, Anaheim

92868

Investigative Site, Orange

93726

Investigative Site, Fresno

95821

Investigative Site, Sacramento

97504

Investigative Site, Medford

98007

Investigative Site, Bellevue

02135

Investigative Site, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zalicus

INDUSTRY

NCT01655849 - Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy | Biotech Hunter | Biotech Hunter